Responses
Regular and Young Investigator Award Abstracts
Cellular Therapies
98 NX-0255, a small molecule CBL-B inhibitor, expands and enhances tumor infiltrating lymphocytes (TIL) for use in adoptive cancer immunotherapy
Compose a Response to This Article
Other responses
No responses have been published for this article.